Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Recombinate 250IU

This product is the most expensive of its product family


Contraindicated

Contraindicated
Recombinate 250IU :
Type Medicine Authorised
Originator Biotech (Xyntha 250IU)
Agent Abela Freres
Distributor Abela Freres
Laboratory Baxalta
Responsible Party Baxalta Innovations GmbH
Origin Austria
Manufacturer Baxalta Belgium Manufacturing SA
Origin Belgium
ATC B02BD02

Your comment will appear shortly after approval

Recombinate 250IU :

Revision Date : 20/12/2013


Effect Frequency
Abdominal pain upper Uncommon
Anaphylactic reactions Not known
Anaphylactic shock Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Antibody test positive Not known
Chest discomfort Uncommon
Chest pain Uncommon
Chills Uncommon
Coagulation factor VIII level decreased Uncommon
Complication associated with device Not known
Diarrhoea (Diarrhea) Uncommon
Dizziness Uncommon
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Uncommon
Dyspnoea (dyspnea) Uncommon
Eosinophil count increased Not known
Eye inflammation (Ocular inflammation) Uncommon
Factor VIII inhibition Common
Fatigue Not known
Feeling abnormal Uncommon
Flushing Not known
Haematocrit decreased Uncommon
Haematoma Uncommon
Headache Common
Hot flush Uncommon
Hyperhidrosis Uncommon
Hypersensitivity Not known
Hypotension Not known
Influenza Uncommon
Infusion site pain Not known
Injection site reaction Not known
Laboratory test abnormal Uncommon
Laryngitis Uncommon
Lethargy Not known
Lymphangitis Uncommon
Malaise Not known
Memory impairment Uncommon
Migraine Uncommon
Monocyte count increased Uncommon
Nausea Uncommon
Oedema peripheral Uncommon
Pallor Uncommon
Palpitations Uncommon
Paraesthesia (paresthesia) Not known
Post procedural complication Uncommon
Post procedural haemorrhage Uncommon
Procedural site reaction Uncommon
Pruritus Uncommon
Pyrexia Common
Restlessness Not known
Skin rash Uncommon
Swelling face Not known
Syncope Uncommon
Tachycardia Not known
Tremor Uncommon
Urticaria Uncommon
Vessel puncture site haematoma Uncommon
Vomiting Uncommon
Wheezing Not known

Different Units By MoH Code

Revision Date : no date

Revision Date : no date

Recombinate 250IU  MoH 8910 :
Form Powder and solvent for solution for injection
Packaging Vial (Type I Glass)
Package Size 1+1
Strength 250IU
Storage Condition 2-8°C Do not freeze
Public Price 8140611.78 L.L.
Stratum D
NSSF ✔
Quarantine ✘
Reg. Number 127716/1
Submission date 01/01/2016
Registration Year 2017


Price Comparison

● Country: Switzerland
● Package Size: 1
● Public Price: 280.85 CHF ( 29,045,507.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 280,85 CHF ( 28,957,600.00 LBP )
● Exfactory Price: 233.99 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Italy
● Package Size: 1
● Public Price: 247.56 EUR ( 23,982,622.56 LBP )
● Pack size unit used: 1
● Cost/Unit: 247,56 EUR ( 23,928,372.00 LBP )
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 1
● Public Price: 950.5 AED ( 22,965,030.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 950,5 AED ( 22,952,950.00 LBP )
● Pharmacy Price: 809.96 AED ( 19569443.56 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 1 Vial (Powder) + 1 Vial Solvent (10ml)
● Public Price: 950.5 AED ( 22,965,030.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 950,5 AED ( 22,952,950.00 LBP )
● Pharmacy Price: 809.96 AED ( 19569443.56 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 232.82 EUR ( 22,554,670.32 LBP )
● Pack size unit used: 1
● Cost/Unit: 232,82 EUR ( 22,475,232.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 1+1x2ml
● Public Price: 5697.97 CZK ( 21,760,547.43 LBP )
● Pack size unit used: 1
● Cost/Unit: 5697,97 CZK ( 21,756,843.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Oman
● Package Size: 1
● Public Price: 94.9 OMR ( 21,896,656.60 LBP )
● Pack size unit used: 1
● Cost/Unit: 94,9 OMR ( 21,688,996.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1
● Public Price: 209.12 EUR ( 20,258,709.12 LBP )
● Pack size unit used: 1
● Cost/Unit: 209,12 EUR ( 20,247,084.00 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: UK
● Package Size: 1
● Public Price: 177.5 GBP ( 20,172,697.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 177,5 GBP ( 20,115,873.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Withdrawn

● Country: Bahrain
● Package Size: 5ML
● Public Price: 80.11 BHD ( 19,044,870.74 LBP )
● Pack size unit used: 1
● Cost/Unit: 80,11 BHD ( 19,018,720.00 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 1hgl
● Public Price: 28044 ISK ( 18,088,380.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 28044 ISK ( 18,088,380.00 LBP )
● Pharmacy Price: 19313 ISK ( 12456885 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: KSA
● Package Size: 1
● Public Price: 668.4 SAR ( 15,800,976.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 668,4 SAR ( 15,791,520.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder and solvent for solution for injection
● Package Size: 1+1
● Public Price: 8140611.78 LBP ( 8,140,611.78 LBP )
● Pack size unit used: 1
● Cost/Unit: 8140611,78 LBP ( 8,140,611.00 LBP )
● Pricing Date: 13/06/2024

● Country: The Netherlands
● Package Size: 1
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Non Marketed

● Country: Greece
● Package Size: 1
● Reference: National Organization for Medicines
● Pricing Date: 25/03/2019
● Type: Medicine Non Marketed

● Country: Portugal
● Package Size: 1
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019
● Type: Medicine Authorised

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 1 inj
● Exfactory Price: 210 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 280,85 CHF ( 28,957,600.00 LBP )
● Cost/Day: 280,85 CHF ( 28,957,600.00 LBP )
● Cost/Month: 8425,5 CHF ( 871,313,500.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 247,56 EUR ( 23,928,372.00 LBP )
● Cost/Day: 247,56 EUR ( 23,928,372.00 LBP )
● Cost/Month: 7426,8 EUR ( 719,401,176.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 950,5 AED ( 22,952,950.00 LBP )
● Cost/Day: 950,5 AED ( 22,952,950.00 LBP )
● Cost/Month: 28515 AED ( 688,950,915.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 950,5 AED ( 22,952,950.00 LBP )
● Cost/Day: 950,5 AED ( 22,952,950.00 LBP )
● Cost/Month: 28515 AED ( 688,950,915.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 232,82 EUR ( 22,475,232.00 LBP )
● Cost/Day: 232,82 EUR ( 22,475,232.00 LBP )
● Cost/Month: 6984,6 EUR ( 676,581,984.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 5697,97 CZK ( 21,756,843.00 LBP )
● Cost/Day: 5697,97 CZK ( 21,756,843.00 LBP )
● Cost/Month: 170939,1 CZK ( 652,816,041.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 94,9 OMR ( 21,688,996.00 LBP )
● Cost/Day: 94,9 OMR ( 21,688,996.00 LBP )
● Cost/Month: 2847 OMR ( 656,899,698.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 209,12 EUR ( 20,247,084.00 LBP )
● Cost/Day: 209,12 EUR ( 20,247,084.00 LBP )
● Cost/Month: 6273,6 EUR ( 607,703,148.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 177,5 GBP ( 20,115,873.00 LBP )
● Cost/Day: 177,5 GBP ( 20,115,873.00 LBP )
● Cost/Month: 5325 GBP ( 605,180,925.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 80,11 BHD ( 19,018,720.00 LBP )
● Cost/Day: 80,11 BHD ( 19,018,720.00 LBP )
● Cost/Month: 2403,3 BHD ( 571,274,802.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 28044 ISK ( 18,088,380.00 LBP )
● Cost/Day: 28044 ISK ( 18,088,380.00 LBP )
● Cost/Month: 841320 ISK ( 542,651,400.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 668,4 SAR ( 15,791,520.00 LBP )
● Cost/Day: 668,4 SAR ( 15,791,520.00 LBP )
● Cost/Month: 20052 SAR ( 474,029,280.00 LBP )
Treatment and prophylaxis of bleeding in patients with haemophilia A :
● Cost/Unit: 8140611,78 LBP ( 8,140,611.00 LBP )
● Cost/Day: 8140611,78 LBP ( 8,140,611.00 LBP )
● Cost/Month: 244218353,4 LBP ( 244,218,353.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info